Medical. Pharmacology. Seventh Edition. KD TRIPATHI MD. Ex-Director- Professor and Head of Pharmacology. Maulana Azad Medical College and associated. I upload this so that the students who willing to read can read easily TY;). Textbook of Biochemistry - For Medical Students, 6th Edition Downloads·New! of Medical Pharmacology, 6th Edition KD Tripathi Essentials of Medical Pha.
|Language:||English, Spanish, Indonesian|
|Distribution:||Free* [*Registration Required]|
Beginning with an introduction to general pharmacological No eBook available Essentials of Medical Pharmacology KD Tripathi. Essentials of Medical Pharmacology. Front Cover. K. D. Tripathi. Jaypee Brothers Drug Benefits and Risks: International Textbook of Clinical Pharmacology. KD Tripathi Pharmacology Ebook PDF Download. With some weird diagrams, KD Tripathi still manages to explain the mechanism of drugs.
Book given details about topics which are not given in KD Tripathi for example Schedule of drugs in India, laws related to drugs in India, dosage forms of drugs and sources of drugs. This book is a very good alternative to KD Tripathi and many of the post-graduate MD Pharmacology students also read this book for their final exams because of writing style which is better than KD Tripathi.
The negative thing about this book is that is is not as detailed as Tripathi and thus students who like to read more will be dissatisfied with this book. But it is a very good alternative for students who are short of time. Pharmacology for Medical Graduates by Tara Shanbhag Basic and Clinical Pharmacology by Bentram Katzung Recommended A typical book from Lange publishers which focuses more on understanding the mechanisms and clinical relevance of drugs rather than going into minor details of the drugs.
I have always liked all books from LANGE as they are better than any other book when it comes to understanding a subject. Book give physiology of the topic before the pharmacology which makes it very easy to understand the basics of the pharmacological mechanisms.
General Pharmacology is not given in much details and students should refer to Sharma or Tripathi for that. This book is best for students who want to understand the subject rather than just blindly mugging up the names of the drugs. It is only for postgraduate students of pharmacology and not for undergraduates.
General pharmacology in this book is not given properly but other topics are given in so much details that it is difficult to read and revise this complete book. I still remember many of my undergraduate batchmates reading this book for general pharmacology.
I am not a big fan of this book and its writing style. Kulkarni Fundamentals of Experimental Pharmacology by M. Ghosh Another book for MD Pharmacology resident doctors who want to learn about experimental pharmacology.
Screening Methods in Pharmacology by N. Dizziness and drowsiness are very common side-effects, as are agitation, anxiety, confusion, irritability, paraesthesia and sleep disturbance. Lofepramine - used to treat depressive illness. Common side-effects include dizziness, agitation, anxiety, confusion, irritability, paraesthesia, postural hypotension and sleep disturbance Dosulepin hydrochloride- used for depressive illness especially where sedation is required.
Common side-effects include dizziness, agitation, anxiety, confusion, irritability, paraesthesia, postural hypotension and sleep disturbance Desipramine hydrochloride not UK , is approved in the US to treat symptoms of depression. Use of desipramine in patients being treated with MAOI antidepressants e.
Desipramine may cause exacerbation of psychosis in schizophrenic patients. Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug. Imipramine hydrochloride — used for depressive illness and nocturnal enuresis.
Common side-effects include fatigue, flushing, headache, palpitations and restlessness. Nortriptyline — prescribed for depressive illness and neuropathic pain. Treatment should be stopped if the patient enters a manic phase.
Common side-effects include fatigue, hypertension, mydriasis and restlessness Amoxapine not UK - used to treat symptoms of depression, anxiety, or agitation. Do not use this medicine within 14 days of taking an MAOI antidepressant.
Clomipramine hydrochloride- prescribed for depressive illness, phobic and obsessional states and as an adjunctive treatment of cataplexy associated with narcolepsy. Common side-effects include abdominal pain, aggression, diarrhoea, fatigue, flushing, hypertension, impaired memory, muscle hypertonia, muscle weakness, mydriasis, myoclonus, restlessness and yawning. Maprotiline not UK - used to treat major depressive disorder, depressive neurosis, and manic-depression illness.
Avoid alcohol as it can increase some of the side-effects of maprotiline.
Maprotiline can impair thinking or reactions, so patients are recommended to avoid activities that require alertness e. Side-effects can include agitation, anorexia, anxiety, arrhythmia, blurred vision, confusion, constipation, dizziness and dry mouth.
Trimipramine is also a serotonin 5-HT2 receptor antagonist. Protriptyline not UK - used to treat symptoms of depression. Common side-effects can include nausea, vomiting, loss of appetite, anxiety, insomnia, dry mouth, little or no urinating and constipation.
Monoamine oxidase inhibitor antidepressants MAOIs MAOIs block the activity of monoamine oxidase, an enzyme that breaks down norepinephrine, serotonin, and dopamine in the brain and other parts of the body. MAOIs are used much less frequently than tricyclic and related antidepressants, or SSRIs and related antidepressants because of the dangers of dietary and drug interactions. MAOIs exhibit some benefit for phobic patients and depressed patients with atypical, hypochondriacal, or hysterical features, but should only be prescribed by specialists.
In general, MAOIs have been replaced by newer antidepressants that are safer and cause fewer side-effects. Common side-effects include postural hypotension, weight gain, and sexual side effects. Isocarboxazid , phenelzine and tranylcypromine are non-selective, irreversible MAOIs, used to manage depressive illness. Rasagiline and selegiline are irreversible MAOB inhibitors used not to treat depression, but to treat Parkinson's disease as a monotherapy or as an adjunct to co-beneldopa or co-careldopa to manage 'end-of-dose' fluctuations.
Atypical antidepressants Each drug in this category has a unique molecular mechanism of action, or a chemical structure that excludes them from the classification above. However, like other antidepressants, atypical antidepressants affect the levels or effects of dopamine, serotonin, and norepinephrine in the brain.
Bupropion - used to aid smoking cessation in combination with motivational support in nicotine-dependent patients.
This drug should not be used in patients with seizure disorders, eating disorders, and within 2 weeks of using MAOI. It generally does not cause weight gain or sexual problems. Used to manage major depression. Nefazodone not UK - a serotonin 5-HT2 receptor antagonist also inhibiting serotonin and norepinephrine re-uptake.
Used to manage depression, including major depressive disorder. Nefazodone should not be prescribed to patients with active liver disease. Trazodone - principally a serotonin 5-HT2 receptor antagonist, used to manage depressive illness, particularly where sedation is required. Vilazodone not UK - a potent serotonin 5-HT1A receptor partial agonist, with combined inhibitory action against serotonin re-uptake.
Used to manage major depressive disorder. Vilazodone is not associated with significant weight gain or sexual dysfunction.
May also inhibit re-uptake of serotonin. Side-effect profiles are as unique as their mechanisms of action. Some common side effects include dry mouth, constipation, dizziness, and light headedness. Mirtazapine and trazodone cause drowsiness and are usually taken at bedtime Note: The drug lists presented here are not exhaustive, but are intended to represent the majority of antidepressants in use in the UK and US.
Additional drugs may be approved in other countries.